Home Industries Market Insights About Us Publisher Contact us

Helicobacter Pylori Diagnostics Market Size, Share & Trends Analysis Report By Technology (Immunoassays, Point Of Care (POC), Molecular Diagnostics, Others), By End-users (Hospitals and Clinics, Diagnostic Laboratories, Others), Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America)—Forecast till 2028

Categories: Life Science

Formate :

The Global Helicobacter Pylori Diagnostics market size is estimated to reach $671 million by 2026, growing at a CAGR of 6.2% over the forecast period of 2021-2026.

 

Global Helicobacter Pylori Diagnostics Market Overview

Helicobacter Pylori Diagnostics includes tests and mechanisms utilized to decide if one has a H.pylori infection. Tests include blood test wherein investigation of a blood sample may disclose proof of an active or prior H.pylori infection in the body.

 

The extensive application of diagnostic tests for Helicobacter Pylori like breath tests, stool tests and blood tests is set to drive the Helicobacter Pylori Diagnostics Market. The soaring predominance of Helicobacter pylori in immigrants arriving from countries with a great pervasiveness of Helicobacter pylori is set to propel the growth of the Helicobacter Pylori Diagnostics Market during the forecast period 2022-2027. This represents the Helicobacter Pylori Diagnostics Industry Outlook.

 

Impact of COVID-19:

Globally the use of In-Vitro diagnostics tests were increased to test for COVID-19, which impacted negatively and backlashed the H.Pylori diagnostics. This has resulted in a significant drop down of revenue for the market. Anyhow, after the business implications of the pandemic and its induced economic crisis, the growth in was readjusted and recovered back strongly.

 

Key Takeaways from Global Helicobacter Pylori Diagnostics Market Report:

  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for technology, end-users and by different industry verticals.
  • Understand the different dynamics influencing the market – key driving factors, challenges, and hidden opportunities.
  • Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep dive on the value augmentation at each step to optimize value and bring efficiencies in your processes.
  • Get a quick outlook on the market entropy – M&As, deals, partnerships, product launches of all key players for the past four years.
  • Evaluate the supply-demand gaps, import-export statistics, and regulatory landscape for more than the top 20 countries globally for the market.

 

By Technology, the market for Immunoassays to grow at the highest CAGR during the forecast period

During the forecast period, the Immunoassays segment is predicted to develop at the fastest rate of XX%. This is owing to soaring technological advancements and the application of chromatographic immunoassays for detection of Helicobacter pylori. The Immunoassays Segment held the largest market share in 2020. This growth is owing to the development of progressive technologies like enzyme immunoassays utilized for the discovery of antibodies. Typical tests are inclusive of urea breath tests, serology, and rapid urease tests. Stool antigen tests have been suggested for the diagnosis of Helicobacter pylori infection. The precise detection of Helicobacter pylori Antigen in human stool specimens by two novel immunoassays has been performed.  The expanding predominance of Helicobacter pylori infections is further propelling the growth of the Immunoassays segment.

 

By End-users, Helicobacter Pylori Diagnostics market for Diagnostic Laboratories to grow at the highest CAGR during the forecast period

During the projection period, the Diagnostic Laboratories is estimated to be the fastest-growing, with a CAGR of XX%, owing to the availability of specially-designed and effective infection detection in conjunction with the heightening awareness about infectious ailments. The Hospitals And Clinics Segment held the largest market share in 2020. This growth is owing to the effortless demonstration of the ailment and easy availability of specialist physicians. Testing is vital not only for detection of Helicobacter pylori but also consequent to treatment, to be certain, that it has been removed. Numerous tests like stool tests, breath tests and scope tests are performed for the detection of Helicobacter pylori. The increasing predominance of ailments like gastritis, stomach cancer and gastric ulcer are further propelling the growth of this segment.

 

North America to account for the largest market share during the forecast period

North America held the largest share of the Helicobacter Pylori Diagnostics market in 2020, with a global market share of 35.7%. The growth of this region is owing to the enlarging predominance of Helicobacter Infections and surging awareness concerning Helicobacter pylori infections in the region. As per statistics on MedlinePlus, maintained by the United States National Library Of Medicine, around 30% to 40% of communities in the U.S. acquire an H. pylori infection. The soaring technological progress in Helicobacter pylori diagnostics and the existence of well-entrenched healthcare infrastructure in the region are further propelling the growth of the Helicobacter Pylori Diagnostics Market in the North American region.

 

The Asia Pacific is also set to be the fastest-growing over the period 2021-2026. This growth is owing to factors like enormous population residing in cramped areas and the unhealthy and poor sanitation in many parts of the developing world in the Asia-Pacific region. The proliferating preference of key players to launch novel products and set up novel production units in this region is further fuelling the progress of the Helicobacter Pylori Diagnostics Market in the Asia-Pacific region.

 

Market Dynamics

Driver:  High Prevalence Of Helicobacter Pylori In Developing Countries Is Projected To Drive The Growth Of Helicobacter Pylori Diagnostics Market.

Communities residing in developing countries where cramped and unclean living conditions could be typical have a greater hazard of H. pylori. There are many areas in developing countries where a trustworthy supply of clean water is not available. People frequently live in cramped conditions and with somebody who is infected with H.pylori. The pervasiveness of this infection has been quoted to be as high as 80% in developing countries inclusive of India. As per updates by World Health Organization, H.pylori infection is typical with a predominance of 50% worldwide, but with considerable country-to-country differences and frequently, rates are greater in developing countries than in developed countries, the exception being East European countries where the pervasiveness of the infection is soaring. Among communities in developing countries, innumerable people are infected with peptic ulceration in the course of their lifetime and more may advance to gastric cancer. Likely mechanisms of H. pylori transmission usually supposed are by way of direct contact between family members and also by way of infected water and food. The soaring predominance of Helicobacter Pylori in developing countries is therefore fuelling the growth of the Helicobacter Pylori Diagnostics Market.

 

Challenge: Elimination Of helicobacter Pylori Infection Presents Challenges To The Growth Of The Helicobacter Pylori Diagnostics Market.

The elimination of H. pylori infection persists as a challenge owing to the development of medication-resistant bacteria, dearth of a gold standard diagnostic technique and inefficiency of recent vaccines. In addition, there still is no general agreement in the written format regarding the principal source of gastric H. pylori contamination. The bacterium has also been displayed to settle in dental plaque and the oral cavity. It is thought that to build novel techniques for favorable elimination of the ailment, determinants like the biology of the bacterium, reservoir distinctions, host-bacterium interplays and issues in diagnosis, treatment and vaccination need to be completely regarded. This issue is hampering the growth of the Helicobacter Pylori Diagnostics Market.

 

Key Market Players

Key Players in the Global Helicobacter Pylori Diagnostics Market consist of Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Cardinal Health, Inc., Halyard Health, Inc., F. Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.), Quest Diagnostics Incorporate, among others.

 

Recent Developments:

  • In October 2021, Bio-Rad Laboratories, Inc. declared the introduction of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System, real-time PCR detection systems that have been catalogued with the U.S. Food and Drug Administration (FDA) for IVD testing and that meet the CE-IVD requirement for IVD application in Europe. Both systems are also recorded with regulatory bodies for IVD application in Singapore and Canada. The CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System are the most recent inclusions to Bio-Rad's portfolio of real-time PCR devices. The systems provide precise measurement to enhance assay growth and workflow efficacies and output for diagnostic testing and research.

 

Report Coverage and Scope

The report "Global Helicobacter Pylori Diagnostics Market", by Research Informatic covers an in-depth detailed analysis for the following segment which are covered under scope.

 

By Technology

  • Immunoassays
  • Point Of Care (POC)
  • Molecular Diagnostics
  • Others

 

By End-users

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

 

Geography

  • North America
  • Europe
  • APAC
  • RoW

Global Helicobacter Pylori Diagnostics Market Growth, Trend and Forecast 2021-2028

Chapter 1 Helicobacter Pylori Diagnostics Market Overview
1.1 Product Overview and Scope of Helicobacter Pylori Diagnostics
1.2 Helicobacter Pylori Diagnostics Market Segmentation by Type
1.2.1 Global Production Market Share of Helicobacter Pylori Diagnostics by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Helicobacter Pylori Diagnostics Market Segmentation by Application
1.3.1 Helicobacter Pylori Diagnostics Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Helicobacter Pylori Diagnostics Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Helicobacter Pylori Diagnostics (2014-2028)

Chapter 2 Global Economic Impact on Helicobacter Pylori Diagnostics Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Helicobacter Pylori Diagnostics Market Competition by Manufacturers
3.1 Global Helicobacter Pylori Diagnostics Production and Share by Manufacturers (2020 and 2020)
3.2 Global Helicobacter Pylori Diagnostics Revenue and Share by Manufacturers (2020 and 2020)
3.3 Global Helicobacter Pylori Diagnostics Average Price by Manufacturers (2020 and 2020)
3.4 Manufacturers Helicobacter Pylori Diagnostics Manufacturing Base Distribution, Production Area and Product Type
3.5 Helicobacter Pylori Diagnostics Market Competitive Situation and Trends
3.5.1 Helicobacter Pylori Diagnostics Market Concentration Rate
3.5.2 Helicobacter Pylori Diagnostics Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Helicobacter Pylori Diagnostics Production, Revenue (Value) by Region (2014-2021)
4.1 Global Helicobacter Pylori Diagnostics Production by Region (2014-2021)
4.2 Global Helicobacter Pylori Diagnostics Production Market Share by Region (2014-2021)
4.3 Global Helicobacter Pylori Diagnostics Revenue (Value) and Market Share by Region (2014-2021)
4.4 Global Helicobacter Pylori Diagnostics Production, Revenue, Price and Gross Margin (2014-2021)
4.5 North America Helicobacter Pylori Diagnostics Production, Revenue, Price and Gross Margin (2014-2021)
4.6 Europe Helicobacter Pylori Diagnostics Production, Revenue, Price and Gross Margin (2014-2021)
4.7 China Helicobacter Pylori Diagnostics Production, Revenue, Price and Gross Margin (2014-2021)
4.8 Japan Helicobacter Pylori Diagnostics Production, Revenue, Price and Gross Margin (2014-2021)
4.9 Southeast Asia Helicobacter Pylori Diagnostics Production, Revenue, Price and Gross Margin (2014-2021)
4.10 India Helicobacter Pylori Diagnostics Production, Revenue, Price and Gross Margin (2014-2021)

Chapter 5 Global Helicobacter Pylori Diagnostics Supply (Production), Consumption, Export, Import by Regions (2014-2021)
5.1 Global Helicobacter Pylori Diagnostics Consumption by Regions (2014-2021)
5.2 North America Helicobacter Pylori Diagnostics Production, Consumption, Export, Import by Regions (2014-2021)
5.3 Europe Helicobacter Pylori Diagnostics Production, Consumption, Export, Import by Regions (2014-2021)
5.4 China Helicobacter Pylori Diagnostics Production, Consumption, Export, Import by Regions (2014-2021)
5.5 Japan Helicobacter Pylori Diagnostics Production, Consumption, Export, Import by Regions (2014-2021)
5.6 Southeast Asia Helicobacter Pylori Diagnostics Production, Consumption, Export, Import by Regions (2014-2021)
5.7 India Helicobacter Pylori Diagnostics Production, Consumption, Export, Import by Regions (2014-2021)

Chapter 6 Global Helicobacter Pylori Diagnostics Production, Revenue (Value), Price Trend by Type
6.1 Global Helicobacter Pylori Diagnostics Production and Market Share by Type (2014-2021)
6.2 Global Helicobacter Pylori Diagnostics Revenue and Market Share by Type (2014-2021)
6.3 Global Helicobacter Pylori Diagnostics Price by Type (2014-2021)
6.4 Global Helicobacter Pylori Diagnostics Production Growth by Type (2014-2021)

Chapter 7 Global Helicobacter Pylori Diagnostics Market Analysis by Application
7.1 Global Helicobacter Pylori Diagnostics Consumption and Market Share by Application (2014-2021)
7.2 Global Helicobacter Pylori Diagnostics Consumption Growth Rate by Application (2014-2021)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries

Chapter 8 Helicobacter Pylori Diagnostics Manufacturing Cost Analysis
8.1 Helicobacter Pylori Diagnostics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Helicobacter Pylori Diagnostics

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Helicobacter Pylori Diagnostics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Helicobacter Pylori Diagnostics Major Manufacturers in 2020
9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12 Global Helicobacter Pylori Diagnostics Market Forecast (2021-2028)
12.1 Global Helicobacter Pylori Diagnostics Production, Revenue Forecast (2021-2028)
12.2 Global Helicobacter Pylori Diagnostics Production, Consumption Forecast by Regions (2021-2028)
12.3 Global Helicobacter Pylori Diagnostics Production Forecast by Type (2021-2028)
12.4 Global Helicobacter Pylori Diagnostics Consumption Forecast by Application (2021-2028)
12.5 Helicobacter Pylori Diagnostics Price Forecast (2021-2028)

Chapter 13 Appendix

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

What is Helicobacter Pylori Diagnostics?

Helicobacter Pylori Diagnostics includes tests and mechanisms utilized to decide if one has a H.pylori infection. Tests include blood test wherein investigation of a blood sample may disclose proof of an active or prior H.pylori infection in the body.

What is the Helicobacter Pylori Diagnostics market share?

The Global Helicobacter Pylori Diagnostics market size is estimated to reach $671 million by 2026, growing at a CAGR of 6.2% over the forecast period of 2021-2026.

What are the key factors driving the Helicobacter Pylori Diagnostics Market?

The extensive application of diagnostic tests for Helicobacter Pylori like breath tests, stool tests and blood tests is set to drive the Helicobacter Pylori Diagnostics Market. The soaring predominance of Helicobacter pylori in immigrants arriving from countries with a great pervasiveness of Helicobacter pylori is set to propel the growth of the Helicobacter Pylori Diagnostics Market

Which are the top companies operating in Helicobacter Pylori Diagnostics industry?

Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Cardinal Health, Inc., Halyard Health, Inc., F. Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.), Quest Diagnostics Incorporate, among others.

Which region has largest share in Global Helicobacter Pylori Diagnostics Market?

North America held the largest share of the Helicobacter Pylori Diagnostics market in 2020, with a global market share of 35.7%. The growth of this region is owing to the enlarging predominance of Helicobacter Infections and surging awareness concerning Helicobacter pylori infections in the region.

What are the segmentation of Helicobacter Pylori Diagnostics Market?

Market has segmented By Technology (Immunoassays, Point Of Care (POC), Molecular Diagnostics, Others), By End-users (Hospitals and Clinics, Diagnostic Laboratories, Others), Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America)

Choose License Type

Single User

US$ 4700

Multi User

US$ 7200

Corporate User

US$ 9000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Helicobacter Pylori Diagnostics Market Size, Share...

RD Code : HP21